CJC1295

CJC-1295 Research Peptide

Peptides Plus offers CJC-1295 research peptide for controlled laboratory and scientific research. Researchers commonly identify CJC-1295 as a synthetic analogue of growth hormone-releasing hormone (GHRH). Scientific studies have examined this peptide in experimental settings involving peptide signalling and endocrine-related pathways.

Each vial contains 50 mg of CJC-1295 peptide in lyophilized powder form. The clearly labelled format helps researchers identify, document and manage this laboratory research peptide within controlled research environments.

Laboratory and preclinical studies continue to examine the molecular characteristics of CJC-1295 and its interactions with biological signalling systems. This information describes the scientific research context surrounding the compound and does not demonstrate safety, effectiveness or therapeutic benefit in humans or animals.

CJC-1295 Product Specifications

Peptides Plus provides this CJC-1295 research peptide with the following specifications:

• Product: CJC-1295
• Compound type: Synthetic peptide
• Form: Lyophilized peptide powder
• Purity: 99%+
• Testing method: HPLC
• Storage: Refrigerate at 2°C–8°C
• Intended use: Laboratory research
• Country of origin: Canada
• Human use: Not permitted
• Veterinary use: Not permitted

Quality Testing and Documentation

Researchers need consistent identification, testing and documentation when selecting research materials for controlled laboratory work. Independent third-party laboratories test each batch of CJC-1295 peptide to verify purity and identity.

Peptides Plus makes a batch-specific Certificate of Analysis available to support product verification and research documentation. Researchers should review the applicable COA, product label and storage information before adding the material to an established laboratory protocol.

Keep the lyophilized research peptide appropriately stored, sealed and protected from contamination. Laboratory personnel should follow their institution’s procedures for handling, documenting, storing and disposing of research materials.

CJC-1295 for Scientific Research

Researchers have examined CJC-1295 in experimental models involving GHRH-related signalling and associated biological pathways. Scientific investigation continues to explore these mechanisms under controlled research conditions. Researchers should not interpret findings from laboratory or preclinical models as evidence of clinical effectiveness.

Peptides Plus offers CJC-1295 50 mg specifically as a research material for controlled scientific environments. Peptides Plus does not market this product as a pharmaceutical drug, dietary supplement, natural health product, cosmetic ingredient or therapeutic treatment.

The defined vial quantity, lyophilized format and batch documentation help researchers maintain accurate records throughout laboratory workflows. These characteristics also support consistent product identification when laboratories manage multiple research peptide materials or maintain batch-specific research records.

Research Use Only

Qualified researchers should use this CJC-1295 research peptide exclusively for laboratory and scientific research. The product does not diagnose, treat, cure or prevent any disease or medical condition.

Do not consume, inject, inhale, topically apply or otherwise administer this product to humans or animals. Researchers must ensure that their purchase, storage, handling and use of CJC-1295 follow applicable laws, institutional policies and established laboratory protocols.

Peptides Plus provides Canadian research peptides with an emphasis on clear product identification, analytical testing and batch documentation for appropriate scientific research environments.

For laboratory and scientific research purposes only. Not for human or veterinary use.